| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |